Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Janux Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q3 2021
- Shares held
- 27.5M
- +997.8K (+3.8%) vs. Q3 2021
- Total value
- $541.6M
- −$29.6M (−5.2%) vs. Q3 2021
- New holders
- 6
- 19 more added
- Sold out
- 5
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 121 | $2.00K | 0.00% | +121 | New |
| Ameritas Investment Partners, Inc. | 1,014 | $20.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,239 | $24.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,384 | $27.0K | 0.00% | +862+165.1% | Added |
| Royal Bank of Canada | 2,952 | $58.0K | 0.00% | +115+4.1% | Added |
| UBS Group AG | 3,685 | $73.0K | 0.00% | +185+5.3% | Added |
| Metropolitan Life Insurance Co | 4,011 | $79.1K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,784 | $94.0K | 0.00% | +3,029+172.6% | Added |
| MetLife Investment Management | 5,302 | $104.6K | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 5,357 | $105.0K | 0.00% | +5,357 | New |
| American International Group, Inc. | 7,031 | $139.0K | 0.00% | −211−2.9% | Reduced |
| California State Teachers Retirement System | 7,149 | $141.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,634 | $150.0K | 0.00% | +4,691+159.4% | Added |
| Wells Fargo & Company | 8,223 | $163.0K | 0.00% | +8,149+11,012.2% | Added |
| Deutsche Bank AG | 8,618 | $170.0K | 0.00% | +433+5.3% | Added |
| Chicago Partners Investment Group LLC | 11,380 | $188.0K | 0.01% | +1,922+20.3% | Added |
| New York State Common Retirement Fund | 9,521 | $188.0K | 0.00% | +7,221+314.0% | Added |
| Rhumbline Advisers | 11,037 | $218.0K | 0.00% | −73−0.7% | Reduced |
| JPMorgan Chase & Co | 13,288 | $262.0K | 0.00% | +6,814+105.3% | Added |
| Morgan Stanley | 14,479 | $285.0K | 0.00% | +7,777+116.0% | Added |
| Goldman Sachs Group Inc | 14,748 | $291.0K | 0.00% | +14,748 | New |
| Jane Street Group, LLC | 15,746 | $311.0K | 0.00% | +15,746 | New |
| Nuveen Asset Management, LLC | 19,457 | $345.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 27,771 | $548.0K | 0.00% | −18,385−39.8% | Reduced |
| Parkwood LLC | 32,128 | $634.0K | 0.11% | +11,351+54.6% | Added |
| Charles Schwab Investment Management Inc | 33,946 | $670.0K | 0.00% | +1,370+4.2% | Added |
| Bank of New York Mellon Corp | 36,537 | $721.0K | 0.00% | +5,064+16.1% | Added |
| DekaBank Deutsche Girozentrale | 45,000 | $892.0K | 0.00% | +45,000 | New |
| Northern Trust Corp | 115,495 | $2.28M | 0.00% | −1,466−1.3% | Reduced |
| Cerity Partners LLC | 150,933 | $2.98M | 0.05% | +150,933 | New |
| Logos Global Management LP | 185,196 | $3.65M | 0.38% | −61,926−25.1% | Reduced |
| State Street Corp | 211,566 | $4.17M | 0.00% | +36,922+21.1% | Added |
| Geode Capital Management, LLC | 220,527 | $4.35M | 0.00% | +8,647+4.1% | Added |
| Woodline Partners LP | 278,275 | $5.49M | 0.08% | −21,756−7.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 400,000 | $7.89M | 0.01% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 411,871 | $8.13M | 1.62% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 446,266 | $8.80M | 1.65% | 00.0% | Unchanged |
| Vanguard Group Inc | 533,071 | $10.5M | 0.00% | +2,829+0.5% | Added |
| BlackRock Inc. | 1,008,261 | $19.9M | 0.00% | +206,483+25.8% | Added |
| BVF Inc | 1,017,314 | $20.1M | 0.73% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,411,975 | $27.9M | 0.89% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,853,432 | $36.6M | 0.04% | −5,814−0.3% | Reduced |
| Janus Henderson Group PLC | 2,400,893 | $46.6M | 0.02% | −15,511−0.6% | Reduced |
| OrbiMed Advisors LLC | 2,836,386 | $56.0M | 0.73% | −630,000−18.2% | Reduced |
| FMR LLC | 4,991,402 | $98.5M | 0.01% | +1,375,971+38.1% | Added |
| Ra Capital Management, L.P. | 8,670,644 | $171.1M | 3.02% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −65,414−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −59,366−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −40,860−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −124−100.0% | Sold out |